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Abstract: 
The mechanism for the biomimetic synthesis of flavonolignan diastereoisomers in milk thistle is 
proposed to proceed by single-electron oxidation of coniferyl alcohol, subsequent reaction with 
one of the oxygen atoms of taxifolin’s catechol moiety, and finally, further oxidation to form 
four of the major components of silymarin: silybin A, silybin B, isosilybin A, and isosilybin B. 
This mechanism is significantly different from a previously proposed process that involves the 
coupling of two independently formed radicals. 
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Introduction 
Milk thistle [Silybum marianum (L.) Gaertn. (Asteraceae)] has been used as a medicinal herb 
since antiquity. As outlined in several reviews, modern pharmacological studies typically focus 
on the hepatoprotective properties(1-3) (as milk thistle is the top herbal supplement for hepatitis C 
patients(2)), the prostate cancer chemopreventive properties(4-6) (where promising results have 
been observed, especially for isosilybin B(7-10)), or both. The two most studied formulations are 
either silymarin, an extract of the seeds that contains at least seven major flavonolignans, or 
silibinin, a roughly equimolar mixture of silybin A and silybin B (Figure1); a recent review 
delineates the somewhat confusing nomenclature surrounding the various permutations of milk 
thistle.(11) 
 
Figure 1. Flavonolignans from milk thistle; silibinin is a 1:1 mixture of 1 and 2, while isosilibinin 
is a 1:1 mixture of 3 and 4.(11) 
The chemistry of milk thistle extract has been investigated since the 1960s, and impressive 
strides were made in the isolation and structure determination of the individual flavonolignans 
throughout the 60s, 70s, and 80s, particularly by the competing groups of Hänsel and 
colleagues(12-19) and Wagner and colleagues.(20-25) However, likely because of improvements in 
chromatographic technology, the individual diastereoisomers were not isolated and characterized 
completely until 2003.(26, 27) Subsequently, gram-scale purifications of the individual 
flavonolignans were developed.(28-30) Those materials likely facilitated several chemistry-driven 
investigations, including the generation of analogues,(31-34) an X-ray crystallographic study to 
verify the structures of the four main isomers,(35) and the development of tools to discern and 
quantify flavonolignans by 1H NMR spectroscopy, despite near-identical spectra.(36) 
Structurally, flavonolignans are characterized by the amalgamation of a flavonoid moiety 
(taxifolin) and a phenylpropane unit (coniferyl alcohol) (Scheme 1).(1, 37, 38) Silibinin (silybin A 
and silybin B) and isosilibinin (isosilybin A and isosilybin B) each exist as a pair of trans 
diasteroisomers with respect to the relative configuration at positions C7″ and C8″ in the 1,4-
benzodioxane ring.(26, 27, 35, 36) Silychristin (5) and isosilychristin (6) have coumaran ring systems, 
or dihydrobenzofuran bicycles, but the position of this bicycle differs by being formed at either 
the C4′ and C5′ positions in silychristin or the C2′ and C3′ positions in isosilychristin. Silydianin 
(7) is the most structurally complex of the flavonolignans in silymarin because it contains a 
bicyclo[2.2.2]octenone with a transannular hemiketal.(19, 22, 24) 
 
Scheme 1. Mechanistic Options for the Biomimetic Synthesis of Flavonolignans 
The first biomimetic synthesis of milk thistle flavonolignans was reported in 1977 by Schrall and 
Becker,(39) who used horseradish peroxidase and a cell-free extract of S. marianum suspension 
cultures to produce silibinin from taxifolin (8) and coniferyl alcohol (9) (Scheme 1). Two years 
later, Merlini and co-workers(17) reported an enzyme-free oxidative coupling of taxifolin and 
coniferyl alcohol using Ag2O to yield a mixture of silibinin and isosilibinin. On the basis of those 
results, multiple researchers have reported biomimetic syntheses of flavonolignans and related 
analogues, typically using a silver oxidant.(18, 31, 40-42) The mechanism presented for these, termed 
Freudenberg’s hypothesis, is based on the synthesis of lignin from coniferyl alcohol(43)and has 
been a topic of controversy in recent years.(44, 45) 
The mechanism that has been proposed for the biomimetic synthesis of flavonolignans 1–
4involves single electron oxidation of both coniferyl alcohol and taxifolin individually, followed 
by a combination of these two radicals to produce silibinin and isosilibinin (Scheme 1, Option 1). 
While there is a possibility that this type of pathway could occur within or near the active site of 
an enzyme,(46, 47) the probability of two radicals being formed independently in solution from 
Ag2O and then combining in a productive manner
(18) is unlikely based on first principles of 
reaction kinetics. Because the concentration of both radicals will be extremely low, the reaction 
rate will be essentially zero. Given the absence of an alternative mechanism for the biomimetic 
synthesis of flavonolignans in the current literature, we pursued a more thorough exploration of 
this process. 
Results and Discussion 
The conversion of coniferyl alcohol and taxifolin to silibinin and isosilibinin necessarily requires 
an oxidation. This oxidation is presumably enzyme-catalyzed in nature,(46, 47) but it has been 
shown that silver salts can also efficiently effect this conversion.(18, 31, 40-42) Because silver 
oxidations typically occur through a series of single electron transfers, various mechanistic 
options were explored and resolved (Scheme 1). Specifically, the reaction involves three steps: 
two single electron oxidations and the coupling of taxifolin to coniferyl alcohol (or an oxidized 
variant of either partner). The five options discussed below cover logical combinations of these 
three processes, although it is noted that alternative mechanisms could be taking place, and as 
such, a definitive mechanism cannot be absolutely determined. 
As mentioned earlier, the mechanism proposed in the literature involves simultaneous single-
electron oxidation of both coniferyl alcohol and taxifolin, followed by a combination of the 
resultant radicals to form an ether (14) which undergoes rapid addition of the phenol to the 
electrophilic p-quinone methide to yield silibinin (Option 1; Scheme 1). The same mechanism is 
possible using the other phenoxy radical of taxifolin to produce isosilibinin (omitted from 
Scheme 1 for clarity). Although this mechanism has been proposed based on Freudenberg’s 
hypothesis for lignin biosynthesis,(43) it was difficult to support due to the low concentration of 
each radical. Moreover, taxifolin and coniferyl alcohol would need to oxidize at nearly identical 
rates, otherwise dimerization would be the major pathway. 
A second mechanistic option proceeds via two sequential oxidations of taxifolin to yield an o-
quinone (12). This pathway seemed more plausible, given the precedence for o-quinones to react 
with alkenes in the Diels–Alder reaction.(48) Additionally, the stereospecific nature of the Diels–
Alder reaction would conserve the relative configuration of the dienophile (i.e., the trans 
configuration of the alkene in coniferyl alcohol would deliver the trans configuration at C7″ and 
C8″ as observed in both silibinin and isosilibinin).(35) 
Options 3 and 4 are similar to one another because they both begin with initial oxidation of either 
taxifolin (Option 3) or coniferyl alcohol (Option 4) followed by coupling to either coniferyl 
alcohol or taxifolin, respectively. The resultant radical (13) or (15) would be further oxidized to 
yield silibinin. Unlike Option 1, Options 3 and 4 both seemed plausible, because both coniferyl 
alcohol and taxifolin are electron-rich and are therefore susceptible to oxidation or reaction with 
an electrophile. 
The final option considered had two sequential oxidations of coniferyl alcohol and subsequent 
coupling to taxifolin (Option 5). It has been shown that coniferyl alcohol undergoes oxidation to 
yield coniferyl aldehyde (16);(43) however, an unlikely redox reaction of this aldehyde and 
taxifolin would be required to yield silibinin. For the sake of this study, all five of these options 
were considered while the mechanism was investigated. However, Option 1 seemed unlikely 
because it required a sufficient concentration of both reactive radical intermediates (10 and11), 
whereas Options 2–5 were only dependent on the concentration of either of the singly oxidized 
radicals. 
The biomimetic synthesis was performed with natural taxifolin, isolated from milk thistle extract 
in >90% purity (data not shown), and commercially available coniferyl alcohol. The reactions 
were explored initially on a small scale ( 1 mg taxifolin) and monitored by HPLC; they were 
later scaled up to >100 mg of taxifolin. The reaction conditions were based upon the procedure 
described by Merlini and co-workers,(17) with moderate optimizations. Several solvents, 
oxidizing agents, and temperatures were tested, and the best results were obtained when 1 equiv 
of taxifolin was reacted with 2 equiv of coniferyl alcohol in ethyl acetate containing 4 equiv of 
Ag2O at 75 °C for 96 h (Scheme 2). These conditions afforded a mixture of silybin A (1), silybin 
B (2), isosilybin A (3), and isosilybin B (4) (Scheme 2) in a combined 52% yield with nearly 
equimolar amounts of each flavonolignan (Figure 2 and Supporting Information). 
 
Scheme 2. Biomimetic Synthesis of Silibinin, Isosilibinin, and Other Byproducts 
 
Figure 2. UPLC chromatogram of biomimetic reaction using conditions in Scheme 2. UPLC was 
conducted using a CH3OH/H2O (0.1% formic acid) gradient that was initiated at 5:95, increased 
to 50:50 over 10 min, and then held at that ratio for 2 min at a flow rate of 0.6 mL/min (50 °C) 
using an HSST3 column monitored at 288 nm. 
In addition to flavonolignans 1–4, coniferyl aldehyde 16 and lignan 18 were produced in 
moderate amounts in the biomimetic reaction (Figure 2). Trace amounts of flavonolignans 5–
7also formed during some of the reactions, as determined by UPLC–MS, but the quantities were 
never sufficient to confirm by isolation and NMR analysis. It had been determined previously 
that silymarin consists of silybin A (16.0%), silybin B (23.8%), isosilybin A (6.4%), isosilybin B 
(4.4%), silychristin (11.6%), isosilychristin (2.2%), silydianin (16.7%), and taxifolin (1.6%; 
seeSupporting Information).(10) The biomimetic conditions described herein increased the yield 
of isosilybin B relative to other flavonolignans. This was noteworthy given studies that 
demonstrate its potential in prostate cancer chemoprevention(7-10) and also the challenges it 
presents when isolating it on a multigram scale.(30) Flavonolignans 1–4 were isolated by HPLC in 
greater than 99% purity, and their structures were confirmed by NMR spectroscopy (see 
Supporting Information). 
To explore the mechanistic possibilities involved in this biomimetic process, the oxidative 
coupling of cis-coniferyl alcohol (19) and taxifolin using Ag2O was examined (Scheme 3). If 
Option 2 (Scheme 1) occurred, the product would maintain a cis relationship at C7″ and C8″, 
because the Diels–Alder reaction of an o-quinone has been shown to be stereospecific with 
respect to the relative configuration of the dienophile.(48) With all of the other options, the 
stereochemical information of coniferyl alcohol would be lost when either radical 11 or 13 was 
formed, and a trans relationship at C7″ and C8″ would be produced as the major product because 
this is thermodynamically more favorable. By running the oxidative coupling of cis-coniferyl 
alcohol with taxifolin, it was determined that the identical products (1–4) as trans-coniferyl 
alcohol were generated and that the cis related products (20–23) were not observed. Although it 
was determined that cis-coniferyl alcohol isomerized to trans-coniferyl alcohol under the 
reaction conditions, it occurred much more slowly than the rate of formation of silibinin and 
isosilibinin. Unless either the Diels–Alder reaction is not concerted, which is inconsistent with 
prior results,(48) or cis related products 20–23 rapidly isomerize to trans related products 1–4, 
Option 2 is not viable. On the basis of the results of the reaction of cis-coniferyl alcohol 
(Scheme 3), Option 2 was considered unlikely, but as it could not be definitively excluded, 
additional reactions were performed. 
 
Scheme 3. Mechanistic Investigation for the o-Quinone Diels–Alder Option 
The next reactions that were examined were the oxidation of either coniferyl alcohol or taxifolin 
individually with Ag2O in the absence of the other compound (Scheme 4). Interestingly, 
coniferyl alcohol was rapidly oxidized by Ag2O, whereas taxifolin was practically inert to those 
conditions (Scheme 4 and Supporting Information). The lack of reactivity toward oxidation of 
taxifolin implies that Options 1–3 in Scheme 1 were all not viable mechanisms and simplifies the 
possibilities to only Options 4 or 5. Importantly, further scrutiny of the oxidation of coniferyl 
alcohol in the absence of taxifolin revealed the production of two major products, coniferyl 
aldehyde and lignan 18. This verified that two oxidations of coniferyl alcohol yielded coniferyl 
aldehyde, as expected, and that the initial radical from single-electron oxidation was prone to 
react with an electron-rich phenol of a different molecule of coniferyl alcohol. Hypothetically, if 
taxifolin was in solution with the oxidized radical of coniferyl alcohol, the nucleophilic catechol 
moiety could similarly react to give silibinin and isosilibinin (Option 4). 
 
Scheme 4. Individual Oxidations of Taxifolin and Coniferyl Alcohol 
As mentioned earlier, it was not anticipated that coniferyl aldehyde 16 would react with taxifolin 
to undergo a redox reaction and yield silibinin and isosilibinin. To test this, the reaction of 
coniferyl aldehyde with taxifolin was examined in both the presence and absence of Ag2O 
(Scheme 5). As anticipated, silibinin and isosilibinin were not observed with this reaction. Thus, 
the only remaining viable mechanism of those considered was Option 4, where coniferyl alcohol 
was oxidized; radical 11 reacted with taxifolin, and finally, the compound oxidized further to 
yield silibinin and isosilibinin (Scheme 6). This pathway accounts for the formation of 
flavonolignans 1–4, coniferyl aldehyde 16, and lignan 18. Although not specifically tested, it is 
plausible that the silver salts are involved in the process. Beyond acting as the single-electron 
oxidants, they may coordinate the phenols to position and stabilize the various charges and 
radicals. 
 
Scheme 5. Attempted Coupling of Coniferyl Aldehyde to Taxifolin 
 
Scheme 6. Mechanistically Supported Biomimetic Synthesis of Flavonolignans 
 
Conclusions 
 
In summary, a biomimetic synthesis of four major flavonolignans present in silymarin is 
reported, and the analyses of related reactions were used to support or refute possible 
mechanisms. From this analysis it is proposed that the mechanism for the biomimetic synthesis 
of flavonolignans proceeds by single electron oxidation of coniferyl alcohol, addition of 
taxifolin, and finally oxidation to yield silibinin and isosilibinin. This is contrary to the 
mechanism proposed previously for this process,(18) which involved the coupling of two 
independently formed radicals. While the study presented herein has exclusively examined 
oxidative couplings using Ag2O instead of enzymes to form flavonolignans, it is proposed that 
similar reactivity should be considered for the biosynthesis of related compounds such as 
lignans. 
Experimental Section 
General Information 
All reactions were carried out under a N2 atmosphere with anhydrous conditions. All reagents 
and solvents were purchased and used without further purification. NMR experiments were 
conducted using a spectrometer operating at 500 MHz for 1H and 125 MHz for 13C. Accurate 
mass measurements were acquired using an Orbitrap mass analyzer and an electrospray 
ionization (ESI) source for compounds 1–4 in negative ionization mode via a liquid 
chromatographic/autosampler system that consisted of a UPLC system. Accurate mass 
measurements of 4-(3-hydroxyprop-1-yn-1-yl)-2-methoxyphenol were accomplished using an 
atmospheric pressure chemical ionization (APCI) source under direct infusion flow conditions in 
positive mode ionization. HPLC and UPLC samples were analyzed using a photodiode array 
(PDA) detector. For preparative HPLC, a YMC ODS-A (5 μm, 250 × 20 mm) column was used 
at a 7 mL/min flow rate, and a pentafluorophenyl propyl (PFP; 5 μm, 250 × 21 mm) column was 
used at a 21.2 mL/min flow rate. For analytical HPLC, a YMC ODS-A (5 μm, 150 × 4.6 mm) 
column and a PFP (5 μm, 150 × 4.6 mm) column were used, both at a 1 mL/min flow rate. For 
UPLC, an HSST3 (1.8 μm, 2.1 × 100 mm) column was used at 50 °C at a 0.6 mL/min flow rate 
and monitored at 288 nm. 
Procedure of Biomimetic Synthesis 
Taxifolin was isolated in >90% purity from milk thistle extract (silymarin) via two successive 
reverse phase HPLC methods. The first method utilized a gradient of 15:85 to 50:50 MeOH/H2O 
over 60 min using the YMC ODS-A (5 μm, 250 × 20 mm) column and detected at 288 nm. The 
second method utilized a gradient of 5:90 to 70:30 CH3CN/H2O (0.1% formic acid) over 30 min 
using a PFP (5 μm, 250 × 21 mm) column. 
To a 100 mL round-bottom flask with a stirred solution of taxifolin (106 mg, 0.348 mmol) 
andtrans-coniferyl alcohol (125 mg, 0.696 mmol) in ethyl acetate (30 mL, 0.01 M) under a 
nitrogen atmosphere at ambient temperature was added Ag2O (323 mg, 1.39 mmol). The flask 
was covered with foil and equipped with a reflux condenser. The solution was stirred and heated 
to 75 °C for 96 h under an atmosphere of nitrogen gas. The reaction mixture was cooled to room 
temperature, filtered through Celite, and washed with ethyl acetate. A yellow filtrate was 
concentrated under reduced pressure, dissolved in ethyl acetate (2 mL), and centrifuged through 
a polypropylene Eppendorf tube filter (0.22 μm) to remove any residual silver salts. The crude 
product (225 mg) was purified by reverse-phase HPLC as described below to afford 
flavonolignans with a total yield of 82.6 mg, 52% (21.4 mg, 21.1 mg, 20.7 mg, and 19.5 mg 
for 1,2, 3, and 4, respectively). In addition to the four major compounds, coniferyl 
aldehyde 16 (2.3 mg) and lignan 18 (13.6 mg) were isolated. In addition to having 1H and 13C 
NMR spectra that were identical to prior reports,(36) coinjection of coniferyl aldehyde or the 
individual natural flavonolignans by UPLC was used to confirm their identity (see Supporting 
Information). 1H and13C NMR data were used to confirm the structure of known lignan 18.(49) 
To purify the reaction mixtures, two different reverse-phase columns were utilized, ODS-A (5 
μm, 250 × 20 mm) and PFP (5 μm, 250 × 21 mm). The reaction mixture was first purified using 
a gradient of 20:80 to 50:50 CH3OH/H2O over 90 min and then held for 20 min. Partially 
purified fractions were chromatographed using a similar procedure. Then, for the final 
purification, the PFP column was used with a gradient of 20:80 to 40:60 CH3CN/H2O (0.1% 
formic acid) over 30 min. Each synthetic flavonolignan was purified until >99% pure, as 
measured by analytical UPLC (see Supporting Information). 
4-(3-Hydroxyprop-1-yn-1-yl)-2-methoxyphenol 
To a stirred solution of 4-bromo-2-methoxyphenol (1.00 g, 4.93 mmol), CuI (282 mg, 0.148 
mmol, 3 mol %), and bis(triphenylphosphine)palladium(II) dichloride (104 mg, 0.148 mmol, 3 
mol %) in triethylamine (10 mL) under a nitrogen atmosphere at ambient temperature was added 
propargyl alcohol (440 mg, 7.9 mmol). The reaction was heated to 95 °C for 4 h, cooled to room 
temperature, filtered through Celite, and concentrated under reduced pressure. The crude extract 
was purified by silica gel column chromatography (85:15 hexanes/ethyl acetate) to yield 80 mg 
of 4-(3-hydroxyprop-1-yn-1-yl)-2-methoxyphenol (9% yield) as a white solid. 1H NMR (500 
MHz, CDCl3) δ = 3.89 (s, 3H), 4.48 (s, 2H), 5.74 (s, 1H), 6.86 (d, J = 8.1 Hz, 1H), 6.95 (d, J = 
1.5 Hz, 1H), 7.0 ppm (dd, J = 8.1, 1.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ = 51.9, 56.1, 
85.5, 86.1, 114.1, 114.2, 114.7, 125.8, 146.3, 146.6. HRMS (APCI) (m/z): 179.0698 [M + 
H]+ calcd for C10H11O3; found, 179.0703). 
(Z)-4-(3-Hydroxyprop-1-en-1-yl)-2-methoxyphenol or cis-Coniferyl Alcohol 19 
To a stirred solution of 4-(3-hydroxyprop-1-yn-1-yl)-2-methoxyphenol (72 mg, 0.40 mmol) and 
Lindlar’s catalyst (0.016 g, 37 mol %) in 10 mL of methanol was added an atmosphere of 
hydrogen gas at ambient temperature. The reaction mixture was stirred for 1 h, filtered through 
Celite, concentrated under reduced pressure, and purified by silica gel column chromatography 
(80:20 hexanes/ethyl acetate) to yield 37 mg of cis-coniferyl alcohol (51% yield) as a white 
solid. The 1H NMR spectrum was consistent with previously reported data (Supporting 
Information).(50) 
Supporting Information 
UPLC chromatograms, 1H and 13C NMR spectra, and tabulated comparisons between isolated 
and synthesized compounds. This material is available free of charge via the Internet at 
http://pubs.acs.org. 
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